Require the Department of Veterans Affairs to submit annual reports to Congress on clinical outcomes, research, and success of innovative therapies for veterans.

Tim Sheehy · Montana · Republican

oversight impact 5.00 specificity 1.00 extraction confidence 92%

Occurrences

Equally important, it would require annual reports to Congress on clinical outcomes, research and success from innovative therapies so we could evaluate what works and establish those best practices Department-wide.

Sheehy commits to mandating that the VA submit yearly reports to Congress detailing the effectiveness and progress of novel therapies provided to veterans.

Sheehy Introduces Bipartisan Veterans Health Administration Novel Therapeutics Preparedness Act
primary · press_release · model gpt-4.1

Evidence

On March 27, 2026, Senator Tim Sheehy introduced the bipartisan Veterans Health Administration Novel Therapeutics Preparedness Act. This legislation aims to establish a dedicated Office of Novel Therapeutics within the Department of Veterans Affairs (VA) to enhance veterans' access to innovative health care. A key provision of the bill requires the VA to submit annual reports to Congress detailing clinical outcomes, research, and the success of emerging therapies for veterans.

Senator Sheehy introduced a bill to create an Office of Novel Therapeutics within the VA, mandating annual reports to Congress on clinical outcomes and innovative therapies for veterans.

partial same_term A for effort

Sheehy Introduces Bipartisan Veterans Health Administration Novel Therapeutics Preparedness Act
primary · model gpt-4.1 · confidence 0%

04-30-2026 | S.4220 | Veterans Health Administration Novel Therapeutics Preparedness Act | Latest Action: Committee on Veterans' Affairs. Hearings held.

Sheehy's own legislation page shows S.4220 was still only at the committee-hearing stage as of April 30, 2026, which is concrete legislative action but not enactment.

partial same_term A for effort

Legislation - Senator Tim Sheehy
secondary · model gpt-5.4-mini · confidence 96%

Mr. Sheehy (for himself, Mr. Gallego, Ms. Duckworth, and Mr. Boozman) introduced the following bill; which was read twice and referred to the Committee on Veterans' Affairs.

The bill was introduced and referred to committee, but this official bill record shows no enactment of the annual-report requirement.

never same_term A for effort

S. 4220 (IS) - Veterans Health Administration Novel Therapeutics Preparedness Act - BILLS-119s4220is | Content Details | GovInfo
secondary · model gpt-5.4-mini · confidence 99%

Sheehy's legislation page listed S.4220 with latest action as 'Committee on Veterans' Affairs. Hearings held' on the June 5 update, indicating committee activity but no enactment.

As of the June 5 update, the bill remained at the committee-hearing stage and the promised VA reporting requirement was not yet law.

never same_term A for effort

Legislation - Senator Tim Sheehy
secondary · model gpt-5.4-mini · confidence 98%

GovInfo records S.4220 as introduced in the Senate on March 26, 2026 and referred to the Committee on Veterans' Affairs.

The official bill record shows introduction and committee referral only, with no enacted reporting mandate.

never same_term A for effort

S. 4220 (IS) - Veterans Health Administration Novel Therapeutics Preparedness Act - BILLS-119s4220is | Content Details | GovInfo
secondary · model gpt-5.4-mini · confidence 99%

The Senate office said the bipartisan bill would create a VA Office of Novel Therapeutics and require annual reports to Congress on clinical outcomes, research, and success of innovative therapies.

Sheehy made a concrete legislative attempt to advance the reporting requirement, but this was only an introduction announcement and not delivery.

partial same_term A for effort

Sheehy Introduces Bipartisan Veterans Health Administration Novel Therapeutics Preparedness Act
primary · model gpt-5.4-mini · confidence 95%

Sen. Tim Sheehy announced a bipartisan bill that would create a VA Office of Novel Therapeutics and require annual reports to Congress on clinical outcomes, research, and the success of innovative therapies for veterans.

This is a concrete legislative effort that matches the promise's reporting requirement, but it is only an introduction announcement, not proof of enactment.

partial same_term A for effort

Sheehy Introduces Bipartisan Veterans Health Administration Novel Therapeutics Preparedness Act
primary · model gpt-5.4-mini · confidence 98%

The official bill record shows S. 4220 was introduced in the Senate on March 26, 2026, read twice, and referred to the Committee on Veterans' Affairs; the bill title and summary align with the VA reporting concept, but no enacted law appears here.

Official bill status confirms introduction and referral only, which supports a finding that the promise was not fulfilled as law.

never same_term A for effort

S. 4220 (IS) - Veterans Health Administration Novel Therapeutics Preparedness Act - BILLS-119s4220is | Content Details | GovInfo
secondary · model gpt-5.4-mini · confidence 99%

Sheehy's legislation page listed S. 4220 with latest action 'Committee on Veterans' Affairs. Hearings held' as of the page update, showing continued committee activity but no enactment of the annual-report requirement.

The senator's own legislation page shows the bill still at the hearing stage, which is meaningful effort but not delivery of the promise.

never same_term A for effort

Legislation - Senator Tim Sheehy
secondary · model gpt-5.4-mini · confidence 98%

Assessments

never same_term A for effort

Sheehy made a concrete and serious legislative attempt that directly matched the promise by introducing the bipartisan Veterans Health Administration Novel Therapeutics Preparedness Act, which would have required the VA to submit annual reports to Congress on clinical outcomes, research, and innovative therapies for veterans. But the available record shows the bill was introduced, referred to the Senate Committee on Veterans' Affairs, and later listed only as having hearings held as of June 5, 2026. There is no evidence that the reporting requirement was enacted into law or otherwise imposed on the VA, so the promised outcome was not delivered.

provider codex_cli · model gpt-5.4 · confidence 97%

never same_term A for effort

As a first-term U.S. senator, Tim Sheehy took a serious and concrete legislative step toward this promise by introducing the bipartisan Veterans Health Administration Novel Therapeutics Preparedness Act in March 2026, and the bill included the claimed requirement for annual VA reports to Congress on clinical outcomes, research, and innovative therapies. But the available record shows only introduction, referral, and committee hearings; there is no evidence that the reporting requirement was enacted or otherwise imposed on the VA. Under the federal office standard, that counts as a meaningful attempt but not delivery of the promised outcome.

provider codex_cli · model gpt-5.4 · confidence 98%

never same_term A for effort

Sheehy introduced S.4220, the Veterans Health Administration Novel Therapeutics Preparedness Act, during his current Senate term, and the bill includes the promised annual VA reporting requirement on clinical outcomes, research, and success of innovative therapies. However, the measure has not been enacted and the requirement is not in force; the latest available status shows committee activity only. This is a serious legislative attempt by the candidate, so it merits an effort badge, but not delivery of the promised outcome.

provider codex_cli · model gpt-5.5 · confidence 94%

never same_term A for effort

Senator Sheehy introduced legislation that would require the VA to submit annual reports on clinical outcomes and therapies, reflecting a serious attempt to deliver on the promise. However, there is no evidence the bill became law or that the requirement was enacted, so the outcome was not delivered despite significant legislative effort.

provider openai · model gpt-4.1 · confidence 97%